Literature DB >> 11142349

Purification and characterization of an extracellular serine proteinase from Acanthamoeba castellanii.

J H Cho1, B K Na, T S Kim, C Y Song.   

Abstract

An extracellular proteinase of Acanthamoeba castellanii was purified and its biochemical and pathological properties were characterized. The molecular mass of the purified enzyme was approximately 42 kDa as estimated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and Sephacryl S-200 HR gel-filtration chromatography. Therefore, its structure seemed to be monomeric with a single polypeptide. Its activity was inhibited by the serine proteinase inhibitors diisopropyl fluorophosphate and phenylmethanesulfonyl fluoride. Its activity was optimum at 30 to 50 degrees C with a maximum at 50 degrees C; optimal pH was 8.0. As much as 70% of the enzyme activity was maintained at 50 degrees C for at least 12 h but was rapidly inactivated thereafter. The purified enzyme degraded collagen and rabbit corneal extract. Furthermore, it exhibited strong cytopathic effects on human corneal epithelial cells and fibroblast cells. These suggest the possible role of this enzyme in the pathogenesis of Acanthamoeba.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11142349     DOI: 10.1080/152165400300001534

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  10 in total

1.  Comparison of specific activity and cytopathic effects of purified 33 kDa serine proteinase from Acanthamoeba strains with different degree of virulence.

Authors:  Won-Tae Kim; Hyun-Hee Kong; Young-Ran Ha; Yeon-Chul Hong; Hae Jin Jeong; Hak Sun Yu; Dong-Il Chung
Journal:  Korean J Parasitol       Date:  2006-12       Impact factor: 1.341

2.  Acanthamoeba culbertsoni elicits soluble factors that exert anti-microglial cell activity.

Authors:  Jenica L Harrison; Gabriela A Ferreira; Erinn S Raborn; Audrey D Lafrenaye; Francine Marciano-Cabral; Guy A Cabral
Journal:  Infect Immun       Date:  2010-07-06       Impact factor: 3.441

3.  Identification, purification, and characterization of a secretory serine protease in an Indian strain of Leishmania donovani.

Authors:  Rajdeep Choudhury; Siddhartha Kumar Bhaumik; Tripti De; Tapati Chakraborti
Journal:  Mol Cell Biochem       Date:  2008-06-29       Impact factor: 3.396

4.  Degradation of immunoglobulins, protease inhibitors and interleukin-1 by a secretory proteinase of Acanthamoeba castellanii.

Authors:  Byoung-Kuk Na; Jung-Hwa Cho; Chul-Yong Song; Tong-Soo Kim
Journal:  Korean J Parasitol       Date:  2002-06       Impact factor: 1.341

Review 5.  Acanthamoeba spp. as agents of disease in humans.

Authors:  Francine Marciano-Cabral; Guy Cabral
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

6.  In vitro activity of Acanthamoeba castellanii on human platelets and erythrocytes.

Authors:  A Mattana; L Alberti; G Delogu; P L Fiori; P Cappuccinelli
Journal:  Infect Immun       Date:  2008-11-17       Impact factor: 3.441

7.  Characterization of extracellular proteases of Acanthamoeba genotype T4 isolated from different sources in Iran.

Authors:  Behroz Mahdavi Poor; Abdolhossein Dalimi; Fatemeh Ghafarifar; Fariba Khoshzaban; Jalal Abdolalizadeh
Journal:  Parasitol Res       Date:  2017-10-26       Impact factor: 2.289

Review 8.  An update on Acanthamoeba keratitis: diagnosis, pathogenesis and treatment.

Authors:  Jacob Lorenzo-Morales; Naveed A Khan; Julia Walochnik
Journal:  Parasite       Date:  2015-02-18       Impact factor: 3.000

9.  Morpho-Physiological and Biochemical Criteria of Acanthamoeba spp. Isolated from the Egyptian Aquatic Environment.

Authors:  A Al-Herrawy; M Bahgat; A Mohammed; A Ashour; W Hikal
Journal:  Iran J Parasitol       Date:  2013-04       Impact factor: 1.012

10.  Interactions of free-living amoebae with rice bacterial pathogens Xanthomonas oryzae pathovars oryzae and oryzicola.

Authors:  John J Long; Courtney E Jahn; Andrea Sánchez-Hidalgo; William Wheat; Mary Jackson; Mercedes Gonzalez-Juarrero; Jan E Leach
Journal:  PLoS One       Date:  2018-08-24       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.